STAT+: Cancer vaccines gain momentum, after years of disappointing results
SAN DIEGO — Cancer vaccines have traveled a potholed road over the last decade. But…
Category: AACR
NCI director expresses optimism about next era of cancer research, despite shrinking budget and brain drain
SAN DIEGO — Kimryn Rathmell, director of the National Cancer Institute, gestured toward the screen…
STAT+: New liquid biopsy screening test for pancreatic cancer shows promise in early data
For the vast majority of pancreatic cancer cases, the tumor grows undetected until it has…
STAT+: WHO scientists question Grail’s plan for evaluating its multi-cancer Galleri blood test
A new analysis published Sunday challenges the clinical trial endpoint the cancer screening firm Grail…
STAT+: About half of cancer drugs given accelerated approval don’t improve survival or quality of life
SAN DIEGO — For decades, the Food and Drug Administration’s accelerated approval pathway has helped…
STAT+: Cancer is rising among the young. Study suggests it’s because their cells are aging faster
SAN DIEGO — Cancer cases among younger people have been rising for years, a trend…
STAT+: Why do some blood stem cells go rogue? Study offers clue and possible target
ORLANDO, Fla. – Long before leukemia forms, patients often have a population of blood or…
STAT+: Lilly’s Retevmo shows success in rare tumors. But can doctors identify the patients who would be helped?
Retevmo, a drug developed by Eli Lilly’s Loxo Oncology unit, shows efficacy in tumors beyond…
STAT+: iTeos Therapeutics debuts first data on TIGIT-targeting cancer immunotherapy
ITeos Therapeutics offered the first look at clinical data for its experimental cancer antibody that…
STAT+: Revolution Medicines seeks to bolster case for its lead cancer drug
Revolution Medicines on Saturday presented updated data to bolster the case for its lead cancer…
STAT+: Researchers see a ‘tractable approach’ to taming chromosomal metastasis
The latest hope for stopping untreatable cancers traces its roots to a turn-of-the-century German zoologist,…
STAT+: Early trial shows promise aiming a modified cold-sore virus against brain tumors in children
A therapy that sends a modified cold-sore virus to selectively kill tumor cells and spark…
STAT+: Natural killer cells, primed with an antibody, induce remissions in patients with advanced blood cancer
Two patients with advanced Hodgkin lymphoma were told their tumors were so resistant to treatment…